NKG2A and COVID-19: another brick in the wall

Cell Mol Immunol. 2020 Jun;17(6):672-674. doi: 10.1038/s41423-020-0450-7. Epub 2020 May 7.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antiviral Agents*
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections
  • Humans
  • Killer Cells, Natural*
  • NK Cell Lectin-Like Receptor Subfamily C
  • Pandemics
  • Pneumonia, Viral
  • SARS-CoV-2

Substances

  • Antiviral Agents
  • NK Cell Lectin-Like Receptor Subfamily C